Endologix, Inc. (NASDAQ:ELGX)

CAPS Rating 2 out of 5 
ELGX VS S&P 500 (SPY)

ELGX News and Commentary

How do you think ELGX will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

54 Outperform
11 Underperform
 

All-Star Players

12 Outperform
4 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top ELGX Bull/Bear Pitches

nibs61 (28.25)
Submitted December 17, 2009

Bought this one in my personal portfolio. Endologix, Inc. is a developer of vascular disease treatments, specifically abdominal aortic aneurysms.The company’s primary product is a next-generationendoluminal stent graft, a minimally invasive device… More

Fools bullish on ELGX
are also bullish on:

dustbusterz (< 20)
Submitted November 10, 2007

they may have a great produst or service to offer, but i fail to see any profitability thus far.

Featured Broker Partners


Advertisement